733 related articles for article (PubMed ID: 27746219)
1. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
[TBL] [Abstract][Full Text] [Related]
2. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
3. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
4. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
5. The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer.
Cirillo N
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958796
[TBL] [Abstract][Full Text] [Related]
6. Matrix Hyaluronan Promotes Specific MicroRNA Upregulation Leading to Drug Resistance and Tumor Progression.
Bourguignon LY
Int J Mol Sci; 2016 Apr; 17(4):517. PubMed ID: 27070574
[TBL] [Abstract][Full Text] [Related]
7. ΔNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis.
Compagnone M; Gatti V; Presutti D; Ruberti G; Fierro C; Markert EK; Vousden KH; Zhou H; Mauriello A; Anemone L; Bongiorno-Borbone L; Melino G; Peschiaroli A
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13254-13259. PubMed ID: 29162693
[TBL] [Abstract][Full Text] [Related]
8. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.
Bourguignon LY; Shiina M; Li JJ
Adv Cancer Res; 2014; 123():255-75. PubMed ID: 25081533
[TBL] [Abstract][Full Text] [Related]
10. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells.
Nagase H; Kudo D; Suto A; Yoshida E; Suto S; Negishi M; Kakizaki I; Hakamada K
Pancreas; 2017 Feb; 46(2):190-197. PubMed ID: 27846148
[TBL] [Abstract][Full Text] [Related]
11. Role of Pericellular Matrix in the Regulation of Cancer Stemness.
Avnet S; Cortini M
Stem Cell Rev Rep; 2016 Aug; 12(4):464-75. PubMed ID: 27193782
[TBL] [Abstract][Full Text] [Related]
12. CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients.
Birzele F; Voss E; Nopora A; Honold K; Heil F; Lohmann S; Verheul H; Le Tourneau C; Delord JP; van Herpen C; Mahalingam D; Coveler AL; Meresse V; Weigand S; Runza V; Cannarile M
Clin Cancer Res; 2015 Jun; 21(12):2753-62. PubMed ID: 25762343
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells.
Valla S; Hassan N; Vitale DL; Madanes D; Spinelli FM; Teixeira FCOB; Greve B; Espinoza-Sánchez NA; Cristina C; Alaniz L; Götte M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070901
[TBL] [Abstract][Full Text] [Related]
14. The Role of CD44 and Cancer Stem Cells.
Wang L; Zuo X; Xie K; Wei D
Methods Mol Biol; 2018; 1692():31-42. PubMed ID: 28986884
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.
Park GB; Ko HS; Kim D
Mol Med Rep; 2017 Aug; 16(2):1826-1836. PubMed ID: 28627617
[TBL] [Abstract][Full Text] [Related]
16. High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome.
Tiainen S; Oikari S; Tammi M; Rilla K; Hämäläinen K; Tammi R; Kosma VM; Auvinen P
Breast Cancer Res Treat; 2016 Nov; 160(2):237-247. PubMed ID: 27683279
[TBL] [Abstract][Full Text] [Related]
17. CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells.
Härkönen K; Oikari S; Kyykallio H; Capra J; Hakkola S; Ketola K; Thanigai Arasu U; Daaboul G; Malloy A; Oliveira C; Jokelainen O; Sironen R; Hartikainen JM; Rilla K
Cells; 2019 Mar; 8(3):. PubMed ID: 30909497
[TBL] [Abstract][Full Text] [Related]
18. The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression.
Nikitovic D; Kouvidi K; Karamanos NK; Tzanakakis GN
Biomed Res Int; 2013; 2013():929531. PubMed ID: 24083250
[TBL] [Abstract][Full Text] [Related]
19. CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage.
Gasbarri A; Del Prete F; Girnita L; Martegani MP; Natali PG; Bartolazzi A
Melanoma Res; 2003 Aug; 13(4):325-37. PubMed ID: 12883358
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan synthases posttranslational regulation in cancer.
Vigetti D; Passi A
Adv Cancer Res; 2014; 123():95-119. PubMed ID: 25081527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]